Stojanovic A - Search Results

1

Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer Cells.

Siegler JJ, Correia MP, Hofman T, Prager I, Birgin E, Rahbari NN, Watzl C, Stojanovic A, Cerwenka A. Siegler JJ, et al. Among authors: stojanovic a. Front Immunol. 2022 Mar 1;13:742571. doi: 10.3389/fimmu.2022.742571. eCollection 2022. Front Immunol. 2022. PMID: 35300331 Free PMC article.

2

Regulatory T cells control macrophage accumulation and activation in lymphoma.

Galani IE, Wendel M, Stojanovic A, Jesiak M, Müller MM, Schellack C, Suri-Payer E, Cerwenka A. Galani IE, et al. Among authors: stojanovic a. Int J Cancer. 2010 Sep 1;127(5):1131-40. doi: 10.1002/ijc.25132. Int J Cancer. 2010. PMID: 20027632

3

Natural killer cells and solid tumors.

Stojanovic A, Cerwenka A. Stojanovic A, et al. J Innate Immun. 2011;3(4):355-64. doi: 10.1159/000325465. Epub 2011 Apr 18. J Innate Immun. 2011. PMID: 21502747 Free article. Review.

4

Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.

Schlecker E, Stojanovic A, Eisen C, Quack C, Falk CS, Umansky V, Cerwenka A. Schlecker E, et al. Among authors: stojanovic a. J Immunol. 2012 Dec 15;189(12):5602-11. doi: 10.4049/jimmunol.1201018. Epub 2012 Nov 14. J Immunol. 2012. PMID: 23152559

5

Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.

Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Ni J, et al. Among authors: stojanovic a. J Exp Med. 2012 Dec 17;209(13):2351-65. doi: 10.1084/jem.20120944. Epub 2012 Dec 3. J Exp Med. 2012. PMID: 23209317 Free PMC article.

6

Shaping of NK cell responses by the tumor microenvironment.

Stojanovic A, Correia MP, Cerwenka A. Stojanovic A, et al. Cancer Microenviron. 2013 Aug;6(2):135-46. doi: 10.1007/s12307-012-0125-8. Epub 2012 Dec 16. Cancer Microenviron. 2013. PMID: 23242671 Free PMC article.

7

Toward the next generation of NK cell-based adoptive cancer immunotherapy.

Ni J, Miller M, Stojanovic A, Cerwenka A. Ni J, et al. Among authors: stojanovic a. Oncoimmunology. 2013 Apr 1;2(4):e23811. doi: 10.4161/onci.23811. Oncoimmunology. 2013. PMID: 23734329 Free PMC article.

8

Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage.

Cohnen A, Chiang SC, Stojanovic A, Schmidt H, Claus M, Saftig P, Janßen O, Cerwenka A, Bryceson YT, Watzl C. Cohnen A, et al. Among authors: stojanovic a. Blood. 2013 Aug 22;122(8):1411-8. doi: 10.1182/blood-2012-07-441832. Epub 2013 Jul 11. Blood. 2013. PMID: 23847195 Free article.

9

CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cells.

Stojanovic A, Fiegler N, Brunner-Weinzierl M, Cerwenka A. Stojanovic A, et al. J Immunol. 2014 May 1;192(9):4184-91. doi: 10.4049/jimmunol.1302091. Epub 2014 Mar 31. J Immunol. 2014. PMID: 24688023

10

Chronic liver inflammation and hepatocellular carcinogenesis are independent of S100A9.

De Ponti A, Wiechert L, Stojanovic A, Longerich T, Marhenke S, Hogg N, Vogel A, Cerwenka A, Schirmacher P, Hess J, Angel P. De Ponti A, et al. Among authors: stojanovic a. Int J Cancer. 2015 May 15;136(10):2458-63. doi: 10.1002/ijc.29282. Epub 2014 Nov 13. Int J Cancer. 2015. PMID: 25331529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters